<DOC>
	<DOCNO>NCT02053818</DOCNO>
	<brief_summary>To evaluate effect cognitive function , recovery , cardioprotection haemodynamics standard Remifentanil anaesthesia standard Sufentanil anaesthesia patient undergoing coronary artery bypass without aortic valve replacement .</brief_summary>
	<brief_title>Remifentanil/Sufentanil CABG+/-AVR Evaluated Recovery , Cognitive Function , Haemodynamics Biochemical Markers .</brief_title>
	<detailed_description>1 . Haemodynamic effect , evaluate invasive haemodynamic data ( arterial line PAC ) opioid give single drug combination Propofol ( first 30 patient ) . 2 . Cognitive dysfunction evaluate standard test preoperative postoperative day 1 , 4 30 3 . Recovery quality time parameter use objective ICU score criterion 4 . Cardioprotection effect evaluate myocardial biochemical marker obtain preoperative postoperative 4 , 9 18 hour</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Patients schedule coronary artery bypass grafting ( CABG ) +/ aortic valve replacement ( AVR ) Ejection Fraction &lt; 30 % Previous Myocardial Infarction within 4 week Severe pulmonary hypertension ( mean pulmonary artery pressure ( mPAP ) &gt; 33 % mean arterial pressure ( MAP ) Arterial hypertension ( Sap &gt; 180 , Dap &gt; 110 ) Diabetes , Non Insulin dependent Non usable echocardiography window</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Cognitive dysfunction</keyword>
	<keyword>Cardioprotection</keyword>
	<keyword>Recovery</keyword>
	<keyword>Renal function</keyword>
	<keyword>ICU discharge</keyword>
</DOC>